Table of Contents: CATIE TreatmentUpdate - 2004


Canadian AIDS Treatment Information Exchange
Edited by: Sean Hosein

Table Of Contents

TreatmentUpdate 146: November/December - Vol. 16, No. 7
Selected highlights from the 6th International Workshop on Adverse Drug Reactions and Lipodystrophy, held from October 25-28, 2004, in Washington, DC, appear in this issue of TreamentUpdate
COMPLICATIONS AND SIDE EFFECTS- 1. Lipodystrophy: yesterday, today and tomorrow; 2. Can TH9057 reduce fat deposits?; 3. Nukes and fat wasting; 4. Filling the face: some possible options; 5. Clinical trial compares three face fillers; 6. Cholesterol-lowering drugs and mitochondria; 7. Do statins affect CD4+ cell counts?; 8. Can statins be used as anti-HIV drugs?; 9. German researchers study breath test for uncovering mitochondrial damage


TreatmentUpdate 145: October - Vol. 16, No. 6
VACCINES: Vaccines for HIV — Looking to the future; VACCINES: Vaccines for HIV — Remune returns; VACCINES: Study finds Remune reduces risk of virologic failure; VACCINES: Response to hepatitis A vaccine weak in some PHAs; NUTRITION: Pilot study suggests high-dose niacin is safe and effective for some PHAs; COMPLICATIONS & SIDE EFFECTS: Increase in blood clots found; ADHERENCE: Harvard study finds adherence advice can sometimes backfire;

TreatmentUpdate 144: August/September - Vol. 16, No. 5
ANTI-HIV AGENTS: Is it age or AIDS? Study finds risk of dementia increases with age; ANTI-HIV AGENTS: Unexpected impact of HAART on depression in some women with HIV/AIDS; TESTS: Study explores the consequences of viral load "blips"; NUTRITION: Long-term high-dose carnitine found to help heal damaged nerves

TreatmentUpdate 143: June/July - Vol. 16, No. 4
NUTRITION AND HERBS: Tropical fruit juices and drug interactions; NUTRITION AND HERBS: Researchers study marijuana users in Ontario; NUTRITION AND HERBS: Cholesterol drug side effects may be linked to low nutrient levels; CANCER: Trends in cancer risk among women with HIV/AIDS; CANCER: Cancer risk in older people with HIV/AIDS; CO-INFECTIONS: Hepatitis C virus linked to thyroid problems

TreatmentUpdate 142: April/May - Vol. 16, No. 3
Report from the 5th International Workshop on Pharmacology; ANTI-HIV AGENTS: Hepatitis C treatment and possible interactions with anti-HIV drugs; The puzzle of virologic failure with tenofovir; Once daily anti-HIV therapy in people co-infected with TB; Nelfinavir levels during pregnancy; Unexpected results from a tipranavir study; A protease-only regimen — Kaletra and saquinavir; Saquinavir — Switching from Fortovase to Invirase; No interaction between tenofovir and saquinavir; Saquinavir with fosamprenavir; Atazanavir and saquinavir

TreatmentUpdate 141: March - Vol. 16, No. 2
INTRODUCTION: Report from the 11th annual Conference on Retroviruses and Opportunistic Infections; ANTI-HIV AGENTS: New and different drugs tested in people; ANTI-HIV AGENTS: Low rate of early virologic failure seen with a combination of Trizivir and tenofovir; ANTI-HIV AGENTS: Once-daily lopinavir/ritonavir (Kaletra); COMPLICATIONS & SIDE EFFECTS: Supplements and CD4+ counts: Study finds surprising results; COMPLICATIONS & SIDE EFFECTS: Diabetes risk found higher for HAART users; COMPLICATIONS & SIDE EFFECTS: Disappointing result for rosiglitazone and lipodystrophy

TreatmentUpdate 140: January - Vol. 16, No. 1
ANTI-HIV AGENTS: Switching therapy may help reverse body shape changes; ANTI-HIV AGENTS: Danish study finds survival with HAART similar to some HIV negative people; ANTI-HIV AGENTS: Some American women don't reap a large benefit from HAART; IMMUNE BOOSTERS: Italian study finds immune booster useful against genital warts

Copyright / Staff / How to Contact

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990,2004. AEGiS . All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS , or the party credited as the provider of the content. Please contact the party credited as the provider of the content for permission to reproduce.